
One of its first attacks was on the cross-subsidizing actions of its competitors (reported by Larry Abrams), where these competitors charged more for certain generics to cover price competitions with other, popular drugs. Walmart offers $4 prescriptions on generic (see Retail Wire).
CVS alone was comfortable enough to stand pat. This may unwind. Walmart also offers three percent below cost on prescriptions (see Google) and over time this is pressuring already thin margins. Facing this kind of well orchestrated brutality will put CVS and its loyalty program to the test.
On a happier note, CVS gives a commitment to protect privacy of data collected - see CVS FAQ - showing the other important aspect of loyalty programs, information.
No comments:
Post a Comment